The abstract is read at the publisher; the summary is JClub's.
In a 12-week open-label pilot trial in 20 individuals with early-stage Huntington’s disease, 8-h time-restricted eating was feasible and well tolerated, with favourable clinical and plasma neurofilament light changes.
- Why it matters: Preclinical work suggests time-restricted eating may be neuroprotective in Huntington’s disease, but it has not been tested in people, leaving clinical feasibility and biological signals unclear.
- What they did: The study enrolled 20 participants with early-stage HD and used an 8-h TRE schedule for 12 weeks, alongside standard-of-care diet and activity recommendations, measuring clinical outcomes and plasma neurofilament light.
- The result: TRE was feasible and well tolerated and was associated with favourable changes in clinical measures and plasma neurofilament light levels, supporting further investigation as a lifestyle intervention in HD.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.